F2RL1 and cutaneous melanoma: While it has been found that PAR1 and PAR2 levels are at large upregulated in the majority of epithelial malignancies, both PARs are downregulated in either kidney renal papillary cell carcinoma (for PAR1) and kidney chromophobe and kidney chromophobe and skin cutaneous melanoma (for PAR2).